IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA (PDAC), GALLBLADDER DISEASE PREDICTS TUMOR IN HEAD AND NECK OF THE PANCREAS

被引：0
|
作者：
Mohamed, Ghada
Han, Sungyong
Perrotta, Gerardo
Rastegar, Ryan
Liu, Quin
Watson, Rabindra
Park, Kenneth H.
Gaddam, Srinivas
Pandol, Stephen J.
Lo, Simon K.
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1431
引用
收藏
页码：S1337 / S1338
页数：2
相关论文
共 50 条
  • [21] Circulating tumor DNA methylation as markers for early detection of pancreatic ductal adenocarcinoma (PDAC).
    Liu Xiaoding
    Guo Shiwei
    Ma Chengcheng
    Li Yatong
    Liu Xiaoqian
    Zhang Zhiwen
    Yu Lianyuan
    Dai Menghua
    Shen Shuo
    Wu, Huanwen M.
    Su Zhixi
    He Qiye
    Liu Rui
    Gang Jin
    Liang Zhiyong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [22] Clinical utility of circulating tumor DNA (ctDNA) in resectable pancreatic ductal adenocarcinoma (PDAC)
    Wong, Hui-Li
    Bushell, Kevin
    Karasinska, Joanna
    Arthur, Sarah
    Morin, Ryan
    Schaeffer, David F.
    Renouf, Daniel John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [23] Clinical utility of circulating tumor DNA (ctDNA) in resectable pancreatic ductal adenocarcinoma (PDAC)
    Wong, Hui -Li
    Bushell, Kevin
    Karasinska, Joanna
    Arthur, Sarah
    Morin, Ryan
    Schaeffer, David F.
    Renouf, Daniel John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Characterization of primary and metastatic pancreatic tumors in pancreatic ductal adenocarcinoma (PDAC)
    Martinez-Muniz, Andres E.
    Sivanand, Sharanya
    Vander Heiden, Matthew
    CANCER RESEARCH, 2019, 79 (13)
  • [25] Germline genetic testing in unselected pancreatic ductal adenocarcinoma (PDAC) patients.
    Peters, Mary Linton Bounetheau
    Brand, Randall
    Borazanci, Erkut Hasan
    Stobie, Lindsey
    Dudley, Beth
    Karloski, Eve
    Moser, A. James
    Colvin, Arlene
    Lim, Cynthia
    Bahary, Nathan
    Sun, Weijing
    Rhee, John C.
    Lembersky, Barry C.
    Stoller, Ronald G.
    LaDuca, Holly
    Dolinsky, Jill S.
    Dalton, Emily
    Speare, Virginia
    Black, Mary Helen
    Tung, Nadine M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] Clinical utility of circulating tumor DNA (ctDNA) n resectable pancreatic ductal adenocarcinoma (PDAC)
    Wong, H-L.
    Bushell, K.
    Karasinska, J.
    Arthur, S.
    Pararajalingam, P.
    Morin, R.
    Schaeffer, D. F.
    Renouf, D. J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [27] Comprehensive genomic analysis in metastatic pancreatic ductal adenocarcinoma (PDAC).
    Wong, Hui-Li
    Jones, Martin
    Eirew, Peter
    Karasinska, Joanna
    Schrader, Kasmintan A.
    Lim, Howard John
    Shen, Yaoqing
    Jones, Steven
    Yip, Stephen
    Laskin, Janessa J.
    Marra, Marco
    Schaeffer, David F.
    Renouf, Daniel John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [28] Oral cavity immune response in pancreatic ductal adenocarcinoma (PDAC)
    Marquez, J. P.
    Lucero-Diaz, P. A.
    Matute-Briseno, J. A.
    Rosas-Delgado, M. O.
    Camacho-Hernandez, A.
    Cortez-Vargas, Y.
    Nava-Sanchez, I.
    Montano, G. T.
    Montijo-Fernandez, L. N.
    Perez-Astorga, M. A.
    ANNALS OF ONCOLOGY, 2018, 29 : 44 - 44
  • [29] Hereditary pancreatitis (HP) and the risk of pancreatic ductal adenocarcinoma (PDAC)
    Howes, N
    Lerch, MM
    Charnley, R
    Mössner, J
    Endres, S
    Deviere, J
    Verreman, V
    Lucidi, V
    Ohla, A
    Ihse, I
    Imrie, C
    Steenbergan, W
    Poll, A
    Greenhalf, W
    Ellis, I
    Mountford, R
    Whitcomb, DC
    Neoptolemos, JP
    GUT, 2002, 50 : A43 - A43
  • [30] The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC)
    Tao Lianyuan
    Xiu Dianrong
    Yuan Chunhui
    Ma Zhaolai
    Jiang Bin
    CANCER BIOLOGY & THERAPY, 2018, 19 (04) : 296 - 305
12345